Camptothecin
Top View
- Crystalline Camptothecin-20(S)-O-Propionate Hydrate: a Novel Anticancer Agent with Strong Activity Against 19 Human Tumor Xenografts
- Product Information
- Coencapsulation of Irinotecan and Floxuridine Into Low Cholesterol-Containing Liposomes That Coordinate Drug Release in Vivo ⁎ Paul G
- Cytotoxic Effects of Camptothecin and Cisplatin Combined with Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
- Establishment of a 7-Ethyl-10-Hydroxy-Camptothecin-Resistant Small Cell Lung Cancer Cell Line
- A Pilot Study with Glioblastoma Multiforme Cells GARRET YOUNT, LILIANA SOROCEANU, HUI-JUAN WANG, ERIC SINGER, ROMI YOUNT, TRAN LUU and LI-XI YANG
- Chemopotentiation of Temozolomide, Irinotecan, and Cisplatin Activity by CEP-6800, a Poly(ADP-Ribose) Polymerase Inhibitor
- Evolution of Nitrogen-Based Alkylating Anticancer Agents
- Current Limitations and Recent Progress in Nanomedicine for Clinically Available Photodynamic Therapy
- Camptothecin Data Sheet; F17-6208-3-A; Effective: 04/15/2020; Supersedes: None; 1 Page
- Topoisomerase Levels Determine Chemotherapy Response in Vitro and in Vivo
- Full Prescribing Information for TOPOTECAN INJECTION
- Topoisomerase I-Related Parameters and Camptothecin Activity in the Colon Carcinoma Cell Lines from the National Cancer Institute Anticancer Screen1
- Tailoring Heated Intraperitoneal Mitomycin C for Peritoneal Metastases Originating from Colorectal Carcinoma: a Translational Approach to Improve Survival
- Homocamptothecin, an E-Ring Modified Camptothecin with Enhanced Lactone Stability, Retains Topoisomerase I-Targeted Activity and Antitumor Properties1
- 5-Fluorouracil: Identification of Novel Downstream Mediators of Tumour Response
- Arsenic Trioxide Circumvents Multidrug Resistance Based on Different Mechanisms in Human Leukemia Cell Lines
- Antitumor Activity of Temozolomide Combined with Irinotecan Is Partly Independent of O6-Methylguanine-DNA Methyltransferase